What is Axsome Therapeutics, Inc's Market Cap?

Axsome Therapeutics, Inc's Market Cap is $10.9B, based on as-reported figures from SEC (XBRL) filings.

What is Axsome Therapeutics, Inc's Enterprise Value?

Axsome Therapeutics, Inc's Enterprise Value is $10.8B, based on as-reported figures from SEC (XBRL) filings.

What is Axsome Therapeutics, Inc's Price / Sales?

Axsome Therapeutics, Inc's Price / Sales is 14.0×, based on as-reported figures from SEC (XBRL) filings.

What is Axsome Therapeutics, Inc's EV / Revenue?

Axsome Therapeutics, Inc's EV / Revenue is 13.9×, based on as-reported figures from SEC (XBRL) filings.

What is Axsome Therapeutics, Inc's EV / EBITDA?

Axsome Therapeutics, Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Axsome Therapeutics, Inc's Revenue (TTM)?

Axsome Therapeutics, Inc's Revenue (TTM) is $776.6M, based on as-reported figures from SEC (XBRL) filings.

What is Axsome Therapeutics, Inc's Net Income (TTM)?

Axsome Therapeutics, Inc's Net Income (TTM) is -$191.6M, based on as-reported figures from SEC (XBRL) filings.

What is Axsome Therapeutics, Inc's EBITDA?

Axsome Therapeutics, Inc's EBITDA is -$179.2M, based on as-reported figures from SEC (XBRL) filings.

What is Axsome Therapeutics, Inc's Diluted EPS (TTM)?

Axsome Therapeutics, Inc's Diluted EPS (TTM) is -3.66, based on as-reported figures from SEC (XBRL) filings.

What is Axsome Therapeutics, Inc's EBITDA Margin?

Axsome Therapeutics, Inc's EBITDA Margin is -23.1%, based on as-reported figures from SEC (XBRL) filings.

Axsome Therapeutics, Inc (AXSM) Financial Statements

Axsome Therapeutics, Inc

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00B6G7GM6

XNAS · usd

207.82▲ 1.14 (0.55%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close206.68

Day's Range202.00 – 210.86

52-Week Range112.90 – 260.19

Volume385.7K

Avg Volume624.3K

Share Statistics

Shares Outstanding

Employees925

ExchangeXNAS

Listed2015-11-19

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Axsome Therapeutics, Inc (AXSM)

What is Axsome Therapeutics, Inc's Market Cap?: Axsome Therapeutics, Inc's Market Cap is $10.9B, based on as-reported figures from SEC (XBRL) filings.
What is Axsome Therapeutics, Inc's Enterprise Value?: Axsome Therapeutics, Inc's Enterprise Value is $10.8B, based on as-reported figures from SEC (XBRL) filings.
What is Axsome Therapeutics, Inc's Price / Sales?: Axsome Therapeutics, Inc's Price / Sales is 14.0×, based on as-reported figures from SEC (XBRL) filings.
What is Axsome Therapeutics, Inc's EV / Revenue?: Axsome Therapeutics, Inc's EV / Revenue is 13.9×, based on as-reported figures from SEC (XBRL) filings.
What is Axsome Therapeutics, Inc's EV / EBITDA?: Axsome Therapeutics, Inc's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Axsome Therapeutics, Inc's Revenue (TTM)?: Axsome Therapeutics, Inc's Revenue (TTM) is $776.6M, based on as-reported figures from SEC (XBRL) filings.
What is Axsome Therapeutics, Inc's Net Income (TTM)?: Axsome Therapeutics, Inc's Net Income (TTM) is -$191.6M, based on as-reported figures from SEC (XBRL) filings.
What is Axsome Therapeutics, Inc's EBITDA?: Axsome Therapeutics, Inc's EBITDA is -$179.2M, based on as-reported figures from SEC (XBRL) filings.
What is Axsome Therapeutics, Inc's Diluted EPS (TTM)?: Axsome Therapeutics, Inc's Diluted EPS (TTM) is -3.66, based on as-reported figures from SEC (XBRL) filings.
What is Axsome Therapeutics, Inc's EBITDA Margin?: Axsome Therapeutics, Inc's EBITDA Margin is -23.1%, based on as-reported figures from SEC (XBRL) filings.